Major histocompatibility complex Class II-based therapy for stroke

This review discusses the potential of major histocompatibility complex (MHC) Class II constructs as stroke therapeutics. We focus on the delivery of MHC Class II construct, DRmQ, as a safe and effective treatment for ischemic stroke. DRmQ was observed to attenuate behavioral deficits and decrease m...

Full description

Saved in:
Bibliographic Details
Published inBrain circulation Vol. 7; no. 1; pp. 37 - 40
Main Authors Gonzales-Portillo, Bella, Lee, Jea-Young, Vandenbark, Arthur, Offner, Halina, Borlongan, Cesario
Format Journal Article
LanguageEnglish
Published India Wolters Kluwer India Pvt. Ltd 01.01.2021
Medknow Publications and Media Pvt. Ltd
Medknow Publications & Media Pvt. Ltd
Wolters Kluwer - Medknow
Wolters Kluwer Medknow Publications
Subjects
Online AccessGet full text

Cover

Loading…